neuroClues raises €10 million Series A to become the brain’s stethoscope for early diagnosis of neurological disorders

neuroClues, a French-Belgian MedTech startup empowering clinicians with biomarkers allowing them to identify neurological disorders years before visible symptoms, has raised a €10 million Series A, along with additional non-dilutive funding, bringing the total capital raised by the company to €25 million.  The round is led by Teampact Ventures, White